Psoralidin Size:Solid 2 mg InChi: InChI=1S/C25H25F3N4O6/c1-24(15-31-14-22(32(33)34)29-23(31)38-24)16-35-18-4-2-17(3-5-18)30-12-10-20(11-13-30)36-19-6-8-21(9-7-19)37-25(26

InChi: InChI=1S/C25H25F3N4O6/c1-24(15-31-14-22(32(33)34)29-23(31)38-24)16-35-18-4-2-17(3-5-18)30-12-10-20(11-13-30)36-19-6-8-21(9-7-19)37-25(26

IC50s of these Ca2+ channel antagonists to I(Ca(T)) and L-type Ca2+ channel current (I(Ca(L))) were 1

BRD9757 is absence of a surface-binding motif

also known as MDK1846

Smiles: COC(=O)NCCO[C@H]([C@@H]1CCCN(C1)C(=O)NC[C@H](C[C@H]1CCCOC1)NC)C1=CC(Cl)=CC=C1

Psoralidin Size:Solid 2 mg InChi: InChI=1S/C25H25F3N4O6/c1-24(15-31-14-22(32(33)34)29-23(31)38-24)16-35-18-4-2-17(3-5-18)30-12-10-20(11-13-30)36-19-6-8-21(9-7-19)37-25(26Psoralidin is a metabolic product from the seed of psoraleacorylifolia, possessing anti inflammatory and immunomodulatory effects. Psoralidin inhibits lipopolysaccharide induced bone resorption by suppressing the inflammatory cytokines: TNF and IL 6 expression, as well as the ratio of RNAKL : OPG. Product information CAS Number: 18642 23 4 Molecular Weight: 336. 34 Formula: C20H16O5 Chemical Name: 5,14 dihydroxy 4 (3 methylbut 2 en 1 yl) 8,17